Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Interictal Dysfunction in Epilepsy
Epilepsy
About this trial
This is an interventional supportive care trial for Epilepsy focused on measuring Interictal, Cognitive, Dysfunction, tDCS, transcranial direct current stimulation
Eligibility Criteria
Inclusion Criteria:
- Age 18-64
- Epilepsy diagnosis confirmed by the UMN Comprehensive Epilepsy Center
- Complete seizure logs of the type in standard clinic use at the UMN Comprehensive Epilepsy Center for at least 12 weeks prior to study entry
- Stable CNS medications for the 2 weeks prior to the initiation visit and expected to continue with current medication doses for the two weeks of the intervention
- No diagnosis of mental retardation (IQ not less than 70) or pervasive developmental disorder
- At least one subtest of learning and memory less than --1.5 SD
- Sufficient spoken English so as to be able to comprehend testing procedures
- Competent and willing to provide consent
Exclusion Criteria:
- Occurrence of generalized convulsive status epilepticus or of complex partial status epilepticus within 1 year prior to study entry
- Occurrence of more than 1 generalized tonic-clonic (GTC) seizure per month, or more than 4 complex partial (CP) seizures per week, as reported in the subject's seizure logs for 12 weeks prior to study entry
- Occurrence of GTC seizure within 48 hours before testing
- Any anti-epileptic medication changes or hospitalizations in the previous 4 weeks
- Additional neurologic disorder other epilepsy and cognitive dysfunctions
- History of metallic cranial plates, screws, or implanted devices
- History of craniotomy
Sites / Locations
- University of Minnesota Comprehensive Epilepsy Center(MINCEP)
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Active tDCS
Sham tDCS
There will be a total of 14 visits in the study: will complete a screening visit, an initial visit, 10 session visits with active tDCS(transcranial direct current stimulation) andcognitive remediation therapy, and follow--up visits immediately (within 5 days), 1 and 3 months after the last intervention. Subjects will be informed of their group assignment at the end of the study.
There will be a total of 14 visits in the study: will complete a screening visit, an initial visit, 10 session visits with sham tDCS and cognitive remediation therapy, and follow--up visits immediately (within 5 days), 1 and 3 months after the last intervention. Subjects will be informed of their group assignment at the end of the study.